Evidence map›Paper›PMID 26443864›Full record

ArticleThe Biochemical journal2015

Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates.

Malik M Keshwani, Kendra L Hailey, Brandon E Aubol, Laurent Fattet, Maria L McGlone, Patricia A Jennings, Joseph A Adams

Abstract read
In one paragraph

Article in The Biochemical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. CLK1 reorganizes the splicing factor U1-70K for early spliceosomal protein assembly.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Review
  4. Review
  5. Article
  6. Redox-dependent gating of VDAC by mitoNEET.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Malik M KeshwaniDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Kendra L HaileyDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Brandon E AubolDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Laurent FattetDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Maria L McGloneDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Patricia A JenningsDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Joseph A AdamsDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A. j2adams@ucsd.edu.
University of California San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Clk Kinases and Splicing RegulationR01GM098528 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2012 to 2019
$2.5M
NIGMS NIH HHS GM98528NIGMS NIH HHS R01 GM098528NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Phosphorylation-dependent cell communication requires enzymes that specifically recognize key proteins in a sea of similar, competing substrates. The protein kinases achieve this goal by utilizing docking grooves in the kinase domain or heterologous protein adaptors to reduce 'off pathway' targeting. We now provide evidence that the nuclear protein kinase CLK1 (cell division cycle2-like kinase 1) important for splicing regulation departs from these classic paradigms by using a novel self-association mechanism. The disordered N-terminus of CLK1 induces oligomerization, a necessary event for targeting its physiological substrates the SR protein (splicing factor containing a C-terminal RS domain) family of splicing factors. Increasing the CLK1 concentration enhances phosphorylation of the splicing regulator SRSF1 (SR protein splicing factor 1) compared with the general substrate myelin basic protein (MBP). In contrast, removal of the N-terminus or dilution of CLK1 induces monomer formation and reverses this specificity. CLK1 self-association also occurs in the nucleus, is induced by the N-terminus and is important for localization of the kinase in sub-nuclear compartments known as speckles. These findings present a new picture of substrate recognition for a protein kinase in which an intrinsically disordered domain is used to capture physiological targets with similar disordered domains in a large oligomeric complex while discriminating against non-physiological targets.

Indexed as

Molecular Docking SimulationProtein MultimerizationCell NucleusHumansMyelin Basic ProteinNuclear ProteinsPhosphorylationProtein Serine-Threonine KinasesProtein Structure, TertiaryProtein-Tyrosine KinasesSerine-Arginine Splicing FactorsClk dual-specificity kinasesMyelin Basic ProteinNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSerine-Arginine Splicing FactorsSRSF1 protein, humandockingkinasekineticsoligomerizationphosphorylationsplicing

Identifiers

PMID26443864
PMCPMC5053023
OpenAlexW2231975509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.